Global Shingles (Herpes Zoster) Market Trends and Prospects
The global shingles market is growing due to factors like an aging population. It elaborates on drivers, segmentation, competition, and future trends.
March 18, 2025
by David Orchard-Webb
GSK Singapore announces availability of Shingrix in Singapore for shingles prevention
GlaxoSmithKline (GSK) Singapore announced that a new vaccine to help protect against shingles, Shingrix, is now available in Singapore.
January 10, 2022
by prnasia
Pfizer and BioNTech sign new global collaboration agreement to develop first mRNA-based shingles vaccine
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles...
January 7, 2022
by WorldPharmaNews
US FDA approves Shingrix to prevent shingles in immuno-compromised adults
Shingrix, a non-live, recombinant sub-unit adjuvanted vaccine, given intramuscularly in two doses, was initially approved by FDA in 2017 for the prevention of shingles in adults 50 years of age or older.
July 28, 2021
by expresspharma
Shingrix Approved for Shingles Prevention in Immunocompromised Adults
GlaxoSmithKline plc announced that the US FDA has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged 18 years and older who are or who will be at increased risk of shingles due to ...
July 27, 2021
by americanpharmaceuticalreview
Chickenpox Vaccine Shields Kids From Shingles, Too
Chickenpox Vaccine Shields Kids From Shingles, Too.
June 11, 2019
by drugs
NanoViricides Reaches Agreement on Terms of License for Shingles Virus Drug Development
NanoViricides has reached an agreement on the terms of the license for the drug development against VZV, the virus that causes chickenpox in children and shingles in adults....
February 27, 2019
by americanpharmaceuticalreview
GSK's shingles vaccine scores US approval
GlaxoSmithKline has announced that its shingles vaccine Shingrix (Zoster Vaccine Recombinant, Adjuvanted) has been awarded FDA approval for the prevention of the disease in patients aged 50 or older.
October 24, 2017
by pharmafile
GSK's Shingles vaccine gets unanimous recommendation from FDA Panel
A U.S. Food and Drug Administration advisory panel on Wednesday voted 11-0 for the vaccine for its safety and efficacy
September 15, 2017
by biospectrumasia